The page is the record's research on the issuer — no analyst, no rating, no view.

# JCR Pharmaceuticals Co.,Ltd. (Prime Market: 4552) — research page

As of 2026-11-06 · jp-cm-kg · record version 1

## Identity and listing

The issuer is JCR Pharmaceuticals Co.,Ltd., listed on the Prime Market under ticker 4552. Its LEI is 353800IMIU9CQ1DGOS14 and its ISIN is not on the record (GLEIF maps no ISIN to this LEI). Its security type is Corporate, its segment is not on the record, its sector is 3250 Pharmaceutical, and its jurisdiction is Japan (EDINET domestic filer). Its listing status is listed, not halted.

## The disclosure read

The record holds 13 filings in the window 2025-11-06 to 2026-11-06, across 5 filing days, of which 2 are ad hoc, 9 are regulatory filings and 2 are results. The median gap between filing days is 71.0 days. The latest filing is dated 2026-07-29 and is a regulatory filing, 100 days before the record date 2026-11-06. The Prime Market median is 10 filings, a 29.0-day median cadence gap and 70.0 days median latency across 1557 issuers. The 3250 Pharmaceutical sector median is 8.0 filings, a 49.5-day median cadence gap and 85.0 days median latency across 80 issuers.

## Auditor

The auditor of record is 有限責任監査法人 トーマツ, with its location not on the record. Auditor changes are not on the record.

## Events and halts

Listing, delisting, name change, domicile change and segment move are not on the record, because the register has no lifecycle type map yet. The halt flag shows listed, not halted.

## Orderability

For the client category Qualified Institutional Investors, the outcome is not determinable, because the rule states a product scope and the record carries no instrument class to place within it. The rule version is acm-68000/jp/suitability-principle-fiea-article-40/r1, with the chapter as of 2026-11-04.

## Coverage

The issuer's own investor-relations page names 9 research houses: SBI SECURITIES Co., Ltd., Jefferies (Japan) Limited, Citigroup Global Markets Japan Inc., Daiwa Securities Co. Ltd., Nomura Securities Co., Ltd., Mizuho Securities Co., Ltd., Morgan Stanley MUFG Securities Co., Ltd., Morgan Stanley, and MUFG Securities Co., Ltd.

## Open research

No openly published research notes were found for the issuer.

## Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

## As-of depth

The market's vintage is not sealed. No issuer years are sealed, the market has no earliest sealed date, and the live record began on no recorded date.

## Sources

9 source pages are named on this page; every value above carries its own source page and read date in the numbers.

- https://www.jpx.co.jp/english/markets/statistics-equities/misc/tvdivq0000001vg2-att/data_e.xlsx (identity.exchange)
- https://disclosure2dl.edinet-fsa.go.jp/searchdocument/codelist/Edinetcode.zip (identity.jurisdiction)
- https://api.gleif.org/api/v1/lei-records/353800IMIU9CQ1DGOS14 (identity.lei)
- https://mcp.jp-cm-kg.ai/events/TSE-PRIME/4552 (the disclosure lines)
- https://www.jpx.co.jp/markets/equities/suspended/index.html (the halt flag)
- https://disclosure2.edinet-fsa.go.jp/WZEK0040.aspx?S100YF19 (the auditor)
- https://mcp.jp-cm-kg.ai/book/aio.json (the orderability chapter)
- https://www.jcrpharm.co.jp/en/ir/shareholder/annalyst_coverage/ (coverage)
- https://mcp.jp-cm-kg.ai/record/TSE-PRIME/4552 (the record)

---
Allooloo Technologies Corp. · https://getresearch.ai/jp/TSE-PRIME/4552 · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp